Infection with Streptococcus pneu1110niae is responsible for significant mortality in individuals with a defective humoral response. This diverse group includes patients with the haematological conditions myeloma and chronic lymphocytic leukaemia. Vaccination to prevent pneumococcal infection is recommended by the Department of Health for those individuals in whom disease is likely to be 'more common and/or more dangerous'. The currently recommended 23-valent polysaccharide vaccine has been shown to be poorly immunogenic in patients with myeloma and chronic lymphocytic leukaemia. Responses to vaccination may be improved by conjugation of polysaccharides to immunogenic carrier proteins. Prevenar©, a 7-valent conjugate vaccine has been demons...
Pneumococcal vaccination has been recommended for immunocompromised children, including patients wit...
Streptococcus pneumoniae causes substantial morbidity and mortality. Incidence and severity are incr...
Invasive pneumococcal infection is the most frequent cause of death in patients with immunodeficienc...
Chronic lymphocytic leukemia (CLL) leads to significant immune system dysfunction. The predominant c...
. Since 2012, the 13-valent pneumococcal conjugate vaccine (PCV13) has been recommended in the Unite...
Patients with multiple myeloma and Waldenstrom's macroglobulinemia respond poorly t,o antigenic...
Thirty-nine previously treated Hodgkin's disease (HD) patients were immunized with 7-valent pne...
Relevance. Among the groups at high risk of developing invasive pneumococcal infections, patients wi...
Multiple myeloma (MM), Waldenstrom’s macroglobulinemia (WM), and monoclonal gammopathy of undetermin...
AbstractBackgroundVaccination with the 23-valent pneumococcal polysaccharide vaccine (PPV) has been ...
Background: Pneumococcal vaccine provides protection against invasive pneumococcal disease in popula...
Aim: To study the effect of standard of care therapy on antibody response and functionality followin...
Background. Invasive pneumococcal disease is a life-threatening complication after allogeneic stem c...
use of the pneumococcal 13-valent conjugate vaccine (Prevnar 13®, Pfizer, Inc.) for adults 50 years ...
BACKGROUND: Life-threatening Streptococcus pneumoniae infections often occur after hematopoietic ste...
Pneumococcal vaccination has been recommended for immunocompromised children, including patients wit...
Streptococcus pneumoniae causes substantial morbidity and mortality. Incidence and severity are incr...
Invasive pneumococcal infection is the most frequent cause of death in patients with immunodeficienc...
Chronic lymphocytic leukemia (CLL) leads to significant immune system dysfunction. The predominant c...
. Since 2012, the 13-valent pneumococcal conjugate vaccine (PCV13) has been recommended in the Unite...
Patients with multiple myeloma and Waldenstrom's macroglobulinemia respond poorly t,o antigenic...
Thirty-nine previously treated Hodgkin's disease (HD) patients were immunized with 7-valent pne...
Relevance. Among the groups at high risk of developing invasive pneumococcal infections, patients wi...
Multiple myeloma (MM), Waldenstrom’s macroglobulinemia (WM), and monoclonal gammopathy of undetermin...
AbstractBackgroundVaccination with the 23-valent pneumococcal polysaccharide vaccine (PPV) has been ...
Background: Pneumococcal vaccine provides protection against invasive pneumococcal disease in popula...
Aim: To study the effect of standard of care therapy on antibody response and functionality followin...
Background. Invasive pneumococcal disease is a life-threatening complication after allogeneic stem c...
use of the pneumococcal 13-valent conjugate vaccine (Prevnar 13®, Pfizer, Inc.) for adults 50 years ...
BACKGROUND: Life-threatening Streptococcus pneumoniae infections often occur after hematopoietic ste...
Pneumococcal vaccination has been recommended for immunocompromised children, including patients wit...
Streptococcus pneumoniae causes substantial morbidity and mortality. Incidence and severity are incr...
Invasive pneumococcal infection is the most frequent cause of death in patients with immunodeficienc...